Company Performance Metrics
- Alain J. Gilbert: Non Executive Chairman, Founder & Senior Advisor
- Claude Allary: Co-Founder
Bionest Partners provides advisory and management services to help biotechnology, specialty pharmaceutical, large pharmaceutical companies, medical device companies and their shareholders maximize the value of their assets. The
company, based in Paris with offices in New York and founded in 2003, has a broad customer base ranging from biotech
start-ups to large and established companies. Bionest Partners has broad experience with more than 100 clients including Pfizer, Sanofi Aventis, GSK, Novartis, BiogenIdec, Wyeth, Millennium, MedImmune, Idenix, ProStrakan, Stallergenes, Innate Pharma, Genfit, Jubilant, Axa Private Equity, Blackstone, Candover. The company offers a hands-on approach and its areas of expertise include management consulting (strategy, organization, marketing, due diligence, surrogate management), corporate finance (private placement, IPO support, out-licensing, in-licensing, mergers and acquisitions), entry into Europe and the US (assessment, strategy, do-it-alone/partnering, management support). Bionest has a strong and growing team of consultants as well as a network of associate members whom it deploys to address specific client assignments and/or for particular geo markets.
